PATENT CLAIM ANALYSIS

Application Number: 15749168
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "325000"]

Abstract:
CRISPR/Cas Systems are provided where two or more guide RNAs having different spacer sequence lengths direct an enzymatically active Cas9 having a transcriptional regulator attached thereto to either cut a target nucleic acid or regulate expression of a target nucleic acid.

Claim (Index 25):
The method of  claim 16  wherein the cell is in vitro, in vivo or ex vivo.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.2
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14319289', '15049451', '14674895', '14903728', '14105017']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7269995523280189
- 35 USC 102 Novelty (BERT): 0.5550750797684052
- Combined Prediction Score: 0.7098071050720576
- Mean Citation Score: 478.90802600000006
- Max Citation Score: 500.33353
- Similarity Product: 301.9301158857465

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test